3Marret H,saugel S,Giraudeau B,et al.Power Doppler vascularity index for predicting malignancy of adnexal masses.Ultrasound Ohstet Gyneeol,2005,25(5):508-513.
4Exaeoustos C,Romanini ME,Rinaldo D,et al.Preoperative sonographic features of borderline ovarian tumors.Ultrasound Ohstet Gyneeol,2005,25(1):50-59.
5Yaman C,Fridrik M.Three-dimensional ultrasaUnd to assess the response to treatment in gynecological malignancies.Gyneeol Oncol,2005,97(2):665-668.
6Emoto M,Fujimitsu R,Iwasaki H,et al.D;agnostic challenges in patients with tumors:ease 3.Normal-sized ovarian cancer detected by color doppler ultrasound using a mierobubble eohtrast agent.J Clin Oncol,2003,21(19):3703-3705.
7Ordén MR,Jurvelin js,Kirkinen PP.Kinetics of a US contrast agent in benign and malignant adnexal tumors.Radiology,2003,226(2):405-410.
8Marret H,Sauget S,Giraudeau B,et al.Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.J Ultrasound Med,2004,23(12):1629-1639;quiz 1641-1642.
7D Arcy T J, Jayaram V, Lynch M, et al. Ovarian cancer detected non invasively by contrast enhanced power Doppler ultrasound. Br J Obstet Gynecol,2004,111 (6):619-622.
8Testa AC,Ferrandina G,Fruscella E,et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic disease:a preliminary study. J Ultrasound Med, 2005,24 (9) : 1267-1278.
9de Groot MC,van Zwieten-Boot BJ,van Grootheest AC.Severe adverse reactiobns after the use of sulphur hexafluoride (SonoVue)as an ultrasonographic contrast agent[J].Ned Tijdschr Geneeskd,2004,148(38):1887-1888.
10Abramowicz JS.Ulatrasonographic contrast media:Has the time come in obstetrics and gynecology?[J].J Ultrasound Med,2005,24(4):517-531.
